Add the specialty areas of your choice to tailor to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Perspective interview - Ania Muntau (PKU treatment in children aged under 4)

Muntau 150911

PKU treatment in children aged <4 years

1. What treatments are available for PKU in children aged <4 years?])

2. What are the disadvantages of a protein-restricted diet?

3. How well do parents and their children cope with the diet restrictions?

4. Is BH4 likely to be indicated for use in children aged <4 years in the future?

5. What are the potential advantages of BH4 cofactor treatment?

6. Are there any safety concerns of BH4 cofactor treatment in young children?

7. How do you see PKU treatment of children evolving in the future?

Ania Muntau

Inborn Errors of Metabolism (IEM) and of Molecular Pediatrics
Dr von Hauner Children's Hospital
Munich, Germany